Alexander Lonshteyn
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 22, 2022
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis.Nirmish Shah, Thokozeni Lipato, Ofelia Alvarez
|Dec 15, 2018
Use of colony-stimulating factor primary prophylaxis and incidence of febrile neutropenia from 2010 to 2016: a longitudinal assessment.Derek Weycker, Mark Bensink, Alexander Lonshteyn
|Sep 06, 2018
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis: a retrospective evaluation using Medicare claims.Derek Weycker, Ahuva Hanau, Alexander Lonshteyn
|Jul 03, 2018
Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims.Derek Weycker, Ahuva Hanau, Alexander Lonshteyn
Pageof 1
